Scottsdale Bariatric Center, Scottsdale, Arizona 85258, USA.
Surg Obes Relat Dis. 2010 May-Jun;6(3):267-73. doi: 10.1016/j.soard.2009.09.010. Epub 2009 Sep 26.
Co-morbid conditions in obese patients contribute to the incidence and severity of major complications after bariatric surgery and significantly increase the cost of the procedure. Previous publications have validated the patient factors that increase the risk of mortality; however, it is currently a rare event. The development of a metabolic acuity score (MAS) to augment the body mass index might allow for accurate preoperative assessment and optimal treatment of patients. The present study has proposed a MAS for decreasing major complications.
Prospectively collected outcomes of 2416 patients undergoing Roux-en-Y gastric bypass (n = 1821) or laparoscopic adjustable gastric banding (n = 595) in a community hospital were evaluated for the incidence of major complications, readmissions, and reoperations. Beginning in August of 2006, 1072 patients were divided into MAS groups of 1-4 according to age, body mass index, weight, history of deep vein thrombosis/pulmonary embolism, sleep apnea, diabetes, hypertension, immobility, heart disease, and psychological classification. The acuity groups were compared with each other and with 1344 patients who underwent treatment before the MAS was implemented.
A significant decrease occurred in the readmission rates within 30 days after the MAS was put into practice (8.5% before MAS versus 1.7% after MAS, P <.001) for the Roux-en-Y gastric bypass patients. The postoperative infection rates were lower after implementing the MAS (3.5% before MAS, .7% after MAS, P <.001). After adjusting for random and fixed effects of covariates, the implementation of the MAS significantly reduced the incidence of postoperative internal hernias, infections, deep vein thrombosis, readmissions, and reoperations.
Recognition of specific patient acuity characteristics through the implementation of MAS and aggressive preoperative and perioperative management led to lower major complication rates and decreased the incidence of readmissions and reoperations after bariatric surgery.
肥胖患者的合并症会导致减重手术后发生重大并发症的几率和严重程度增加,并显著增加手术费用。先前的出版物已经验证了增加死亡率风险的患者因素;然而,这目前是一个罕见事件。开发代谢急症评分(MAS)来增强体重指数可能会允许对患者进行准确的术前评估和最佳治疗。本研究提出了一种用于降低重大并发症的 MAS。
对一家社区医院接受 Roux-en-Y 胃旁路术(n = 1821)或腹腔镜可调胃束带术(n = 595)的 2416 例患者的前瞻性收集结果进行评估,以确定重大并发症、再入院和再次手术的发生率。从 2006 年 8 月开始,1072 例患者根据年龄、体重指数、体重、深静脉血栓形成/肺栓塞、睡眠呼吸暂停、糖尿病、高血压、活动受限、心脏病和心理分类,分为 MAS 组 1-4。比较了各组之间以及 MAS 实施前接受治疗的 1344 例患者之间的差异。
实施 MAS 后,Roux-en-Y 胃旁路术后 30 天内的再入院率显著下降(MAS 前为 8.5%,MAS 后为 1.7%,P <.001)。术后感染率较低MAS 实施后(MAS 前为 3.5%,MAS 后为 0.7%,P <.001)。调整随机和固定协变量的影响后,实施 MAS 显著降低了术后内疝、感染、深静脉血栓形成、再入院和再次手术的发生率。
通过实施 MAS 识别特定的患者急症特征,并进行积极的术前和围手术期管理,导致减重手术后重大并发症发生率降低,再入院和再次手术的发生率降低。